Article
Lafora disease: epidemiology, pathophysiology and management.
CNS drugs - 1 Jul 2010
Monaghan Thomas S, Delanty Norman
Abstract excerpt
Lafora disease is a rare, fatal, autosomal recessive, progressive myoclonic epilepsy. It may also be considered as a disorder of carbohydrate metabolism because of the formation of polyglucosan inclusion bodies in neural and other tissues due to abnormalities of the proteins laforin or malin. The condition is characterized by epilepsy, myoclonus and dementia. Diagnostic findings on MRI and neurophysiological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
